Xenikos

Developer of toxin-loaded antibodies for T-cell mediated diseases

placeNijmegen, Gelderland, Netherlands calendar_todayFounded 2009 groups17 employees language xenikos.com

Registered entities

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 113 times.

YearFilings
20162
20171
20191
20201

Investor mix

8 investors on record; lead investors include Sanquin, Oost NL, Veloxis, Medicxi.

Investor typeCountShare
Venture capital338%
Accelerator & incubator113%
Other / undisclosed450%
Coming soon